OnkoDataMed Joins ACM, ICRC-Weyer in Medis Research Group

Medis Research Group, a strategic alliance of Berlin-based clinical research organizations, has recently been joined by yet another CRO from the Berlin area, oncology specialists OnkoDataMed GmbH. - March 19, 2014

2013 Marks Incisive Year for Clinical CRO, ICRC-Weyer

An exciting year 2013 has ended for ICRC-Weyer GmbH, a Berlin-based clinical contract research organization. Prof Dr Geerd Weyer, founder of the company reflects upon the highlights of the past year, most notably marked by the company’s 20th year in business. - December 21, 2013

ICRC-Weyer, Allied Clinical Management Form MEDIS Research Group

The Berlin-based clinical contract research organizations, ICRC-Weyer and Allied Clinical Management, have announced that they have entered into a strategic alliance, as part of the newly founded MEDIS Research Group. - November 16, 2013

ICRC-Weyer to Expand Pharmacovigilance Services for Mid-Sized Pharma Companies

ICRC-Weyer GmbH, a Berlin-based clinical contract research organization, is expanding its pharmacovigilance services for small to mid-sized pharmaceutical companies. - July 24, 2013

ICRC-Weyer to Boost Drug Safety Services for Investigator Trials

The Berlin-based clinical contract research organization (CRO), ICRC-Weyer GmbH, has announced it will boost its drug-safety related Pharmacovigilance Services for Investigator-Initiated Trials amid an increasing demand by trial sponsors. - June 02, 2013

ICRC-Weyer Joins CDISC®, Expands Data Management

ICRC-Weyer GmbH, a German clinical contract research organization (CRO), has expanded its data management team and recently joined the Clinical Data Interchange Standards Consortium (CDISC®) on a gold-level membership. - March 28, 2013

ICRC-Weyer Take Leading Role in Pharmacovigilance Writing for Drug Safety Reporting

The German clinical contract research organization (CRO), ICRC-Weyer GmbH, is extending their Medical Writing Services with specialized Pharmacovigilance Writing, a comprehensive solution for regulatory-compliant drug safety reporting. - March 01, 2013

Clinical CRO ICRC-Weyer to Enhance Pharmacovigilance Risk Management

The Berlin-based clinical contract research organization (CRO) ICRC-Weyer GmbH is adapting a process of integrating medical review procedures into Pharmacovigilance risk management, a method that will lead to better Pharmacovigilance practices. - January 10, 2013

ICRC-Weyer Clinical CRO Looks Back at a Successful Year 2012

ICRC-Weyer GmbH, a clinical contract research organization (CRO) based in Berlin, Germany, has released its review of the year 2012, stating it has been a successful and exciting 12 months for everybody involved in the business. The company looks forward to more constructive partnerships and growth for the year ahead. - December 16, 2012

Clinical CRO ICRC-Weyer Ready for Increase in Advanced Therapy Trials

The clinical contract research organization (CRO) ICRC-Weyer GmbH, based in Berlin, Germany, has announced that the company is prepared for the increasing number of Advanced Therapy trials, a trend that is expected to continue for the next 10 to 15 years. - September 27, 2012

Drug Development Requires Flexibility in Clinical Trial Design: ICRC-Weyer Clinical CRO Interview

Innovation in drug development requires flexibility in the clinical trial design, not merely standardisation, according to Prof Dr Geerd Weyer, Managing Director at ICRC-Weyer clinical contract research organisation. - August 22, 2012

New Medical Coding Procedures at Clinical CRO ICRC-Weyer

The clinical contract research organization (CRO) ICRC-Weyer GmbH, based in Berlin, Germany, has changed its coding procedures for medications, enabling the company to offer enhanced solutions to a broad client base. - July 20, 2012

Clinical CRO ICRC-Weyer to Monitor Advanced Therapy Trials

The clinical contract research organization (CRO) ICRC-Weyer GmbH, based in Berlin, Germany, has extended its clinical monitoring services to advanced therapy trials – an important step towards entering the market of regenerative medicine. - June 22, 2012

ICRC-Weyer Enhance Medical Data Management Services

The German contract research organization, ICRC-Weyer GmbH, has recently increased its efforts to deliver high-quality, expert medical data management services to the clinical research community. With this step, the Berlin-based CRO further consolidates its leading position within the market of mid-sized clinical research services providers. - May 10, 2012

ICRC-Weyer Launch New Social Media Pages

ICRC-Weyer GmbH, a contract research organization (CRO) based in Berlin, Germany, has launched new corporate pages on the world’s leading social networks, Facebook and Google Plus. The company intends to take a pioneering role within the clinical research community by interacting with a global audience and sharing insights with the next generation of clinical research professionals. - April 21, 2012

ICRC-Weyer to Adjust Services Portfolio in Light of New European Health Claim Regulations

The German based contract research organization, ICRC-Weyer GmbH, has adjusted its services portfolio in order to meet new requirements for the European nutrition market. With the recent fundamental changes for health claims on dietary supplement product labels, manufacturers will have to invest in research and development. But only specialized CROs are able to manage the new challenge. - April 06, 2012

Press Releases 1 - 16 of 16